-
Thu19Mar2026Sat21Mar2026
-
Thu26Mar2026Sat28Mar2026
-
Tue07Apr2026Fri10Apr2026Dubai, United Arab Emirates
-
Wed15Apr2026Fri17Apr2026
-
Sat18Apr2026Wed22Apr2026
-
Tue21Apr2026Thu23Apr2026
-
Wed22Apr2026Fri24Apr2026
-
Mon27Apr2026Wed29Apr2026
Latest News
First US patients treated with surface-modified p48 and p64 MW flow...
WallabyPhenox announced today that the first US patients have successfully been treated in the PIANO investigational device exemption (IDE) trial evaluating the company’s p48 and p64...
Features
The evolving role of interventional training in MMA embolisation: integrating simulation...
As middle meningeal artery embolisation (MMAe) for chronic subdural haematoma (cSDH)—already bolstered by randomised trial data and, more recently, by multiple US Food and...
NeuroNews’ top 10 most popular stories of December 2025
Several highlights from the Society of Vascular and Interventional Neurology (SVIN) annual meeting (19–22 November 2025, Orlando, USA) feature on NeuroNews’ final top 10...
Videos
The latest Proctor Picks video instalment highlights how pNOVUS 21 (WallabyPhenox)—a microcatheter optimised for use in neurovascular treatments—is shaping the future of haemorrhagic care. In this complex case, Fathallah Islim (Leeds General Infirmary, Leeds, UK) treats a previously ruptured...


















